Biotech Revenue Forecasting
MadeSimple
PhorecastAI helps biotech startups forecast market potential, assess valuation, and prepare investor materials with AI-driven precision. Transform biotech forecasting with speed, reliability, and insights your stakeholders can trust.
See how easy it is to generate a forecast in under 5 minutes
Trusted by 50+ biotech founders and backed by leading life science VCs
The Problem Every Biotech Faces
Traditional revenue forecasting takes months, costs hundreds of thousands, and still gets it wrong
Traditional Approach
PhorecastAI Solution
1+ Month timeline
Lengthy consulting engagements delay fundraising, BD discussions, and internal decisions
Investor-Ready in minutes
Generate a complete, structured forecast in under 5 minutes - ready for iteration, scenario testing, and pitch use.
€10k+ Cost
High consulting fees, repeated update costs, and reliance on external teams drain the runway at critical stages.
Up to 95% Lower Cost
Subscription-based pricing replaces bespoke consulting, with unlimited iterations as strategy evolves.
Generic models & inadequate analogues
Forecasts typically rely on analogues from unrelated indications or industries, using top-down assumptions that ignore real patient flows.
Epidemiology-Based Forecasting
State-of-the-art models built on prevalence, incidence, diagnosis, eligibility, treatment, and uptake - reflecting real patient dynamics and disease trends.
Opaque & hard to defend
Black-box spreadsheets and undocumented assumptions make investor discussions difficult and risky.
Transparent & defensible by design
Every assumption is explicit, structured, and auditable - easy to explain, challenge, and defend.
Unclear or unverifiable sources
Inputs are blended from consultant experience, private benchmarks, or undisclosed datasets.
Curated & referenced data
Epidemiology, pricing, and market inputs grounded in public literature, real-world data, and clearly referenced benchmarks.
Single-purpose models
Typically limited to topline revenue projections, with financial outputs built separately or manually.
End-to-End decision outputs
Patients, units, revenue, cash-flow, financing needs, dilution, MOIC, and investor-ready reports - generated from one model.
How It Works
Three simple steps to transform your pharmaceutical asset into a comprehensive revenue forecast
Input Pharmaceutical Details
Enter your pharmaceutical asset information, indication, and development stage in our intuitive interface.
- Name & mechanism
- Target indication
- Development phase
- Key clinical data
AI Market Modeling
Our AI analyzes epidemiology data across 12 global regions to model market dynamics and competitive landscape.
- Patient population analysis
- Market penetration curves
- Competitive benchmarking
- Pricing optimization
Generate Forecast
Receive comprehensive revenue and financial projections with sensitivity analysis and investor-ready documentation.
- 20+ year revenue forecast
- Financial and investment projections
- Valuation report
- Presentation materials and data
Build Your Forecast
Make 3 quick selections to see your personalized pharma forecast
Disease Indication
Development Stage
Target Markets
Select one option from each category to generate your forecast
See PhorecastAI in Action
Sample analysis for OncoVant, a small molecule for Non-Small Cell Lung Cancer (NSCLC), demonstrating our platform's comprehensive market modeling capabilities
US Market, Peak Year 2032
USD Millions (2026-2035)
USD Millions - The Path to Profitability
These visualizations demonstrate PhorecastAI's capability to generate investor-ready market analysis with credible epidemiology modeling, revenue projections, and financial planning.
Why Biotech Teams Choose PhorecastAI
Whether you're a biotech founder seeking investment or an investor evaluating opportunities, PhorecastAI delivers the precise insights you need.
For Biotech Founders
Generate comprehensive TAM/SAM/SOM analysis in minutes, not weeks. Perfect for pitch decks, grant applications, and investor meetings when time is critical.
Our AI suggests optimal parameters for prevalence, market share, and pricing based on your pharmaceutical profile. No forecasting expertise required—just accurate, defensible numbers.
Export polished financial models and market forecasts that meet institutional standards. Built-in credibility signals that investors recognize and trust.
Flexible Plans for Every Biotech Team
From free exploration to enterprise-grade strategy. Every plan includes access to 72 diseases and 12 global regions.
Forever
Perfect for small teams starting out
- 3 forecasts
- 72 diseases, 12 regions
- Standard forecasting
- Basic reporting
- Single user
Pricing TBD
Advanced tools for growing biotechs
- 10 forecasts
- AI-powered creation
- Competitive benchmarks
- 20-year revenue + rNPV
- Up to 5 users
- Priority support
Pricing TBD
Unlimited power for large organizations
- Unlimited forecasts
- Custom integrations
- Sensitivity analysis
- Branded exports + API
- Unlimited users
- Dedicated support
Get Early Access Demo
Be among the first to experience PhorecastAI with our exclusive early access demo. Test drive the platform with 3 forecasts across 72 diseases and 12 regions before the official launch.
Feature Comparison
See what's included in each plan
| Features | Free | Pro | Enterprise |
|---|---|---|---|
| Number of forecasts | 3 | 10 | Unlimited |
| Diseases & regions | 72 & 12 | 72 & 12 | 72 & 12 |
| AI-powered creation | Not included | Included | Included |
| Competitive benchmarks | Not included | Included | Included |
| Revenue forecasting | 20-year + rNPV | 20-year + rNPV | 20-year + rNPV + sensitivity |
| Users included | 1 | 5 | Unlimited |
| Support level | Email | Priority email | Dedicated + 24/7 |
Final pricing will be announced at launch. Join the waitlist for early access and special rates.
World-Class Team
Led by industry veterans with deep expertise in biotech strategy, finance, and pharmaceutical development
Leadership Team
Joaquim Nascimento
Founder & CEO
18 years of experience in biopharma strategy, market access, and commercial excellence. Former senior roles at leading pharmaceutical companies.
Marina Lobato
Chief Operating Officer
20 years of experience in finance and investment management. Expert in financial modeling, valuation, and strategic planning for biotech ventures.
Ready to Transform Your Forecasting?
Join 50+ biotech founders who are already using PhorecastAI to accelerate their fundraising and strategic planning